Tuesday 30 November 2010

Farpain




Farpain may be available in the countries listed below.


Ingredient matches for Farpain



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Farpain in the following countries:


  • Indonesia

International Drug Name Search

Thursday 18 November 2010

Ranibeta




Ranibeta may be available in the countries listed below.


Ingredient matches for Ranibeta



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranibeta in the following countries:


  • Germany

International Drug Name Search

Wednesday 17 November 2010

Dygase


Pronunciation: a-mah-LASE/LYE-pase/PRO-tee-ase
Generic Name: Amylase/Lipase/Protease
Brand Name: Examples include Dygase and Lapase


Dygase is used for:

Relieving symptoms of indigestion (eg, feeling of fullness, gas, bloating) that occur after meals.


Dygase is a digestive enzyme combination. It works by helping the body to digest protein, starch, and fat.


Do NOT use Dygase if:


  • you are allergic to any ingredient in Dygase or to pork protein

  • you have inflammation of the pancreas (pancreatitis) or a flare-up of long-term pancreas problems

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dygase:


Some medical conditions may interact with Dygase. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of pancreas problems, stomach or bowel problems (eg, blockage, short bowel syndrome), or cystic fibrosis

Some MEDICINES MAY INTERACT with Dygase. However, no specific interactions with Dygase are known at this time.


Ask your health care provider if Dygase may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dygase:


Use Dygase as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Dygase by mouth with each meal or snack as directed by your doctor.

  • Swallow Dygase whole. Do not break, crush, or chew before swallowing. If you cannot swallow the capsule whole, you may open it and sprinkle the contents over food. Mix the medicine with the food and swallow the entire mixture right away, followed by a glass of water.

  • If you open the capsule, do not breathe in the powder. Some patients may experience an asthma attack or severe allergic reaction (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue) from breathing in the powder.

  • If you miss a dose of Dygase, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once or take a dose without a snack or a meal.

Ask your health care provider any questions you may have about how to use Dygase.



Important safety information:


  • This product may contain tartrazine dye (FD&C Yellow No. 5). This may cause an allergic reaction in some patients. If you have ever had an allergic reaction to tartrazine, ask your pharmacist if your product has tartrazine in it.

  • Contact your doctor if you have loose stools while you take Dygase. Your doctor may need to decrease your dose

  • PREGNANCY and BREAST-FEEDING: It is not known if Dygase can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dygase while you are pregnant. It is not known if Dygase is found in breast milk. If you are or will be breast-feeding while you use Dygase, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Dygase:


All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with Dygase. Seek medical attention right away if any of these SEVERE side effects occur:



Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe or persistent loose stools; severe stomach pain.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Dygase side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center ( http://www.aapcc.org), or emergency room immediately. Symptoms may include diarrhea.


Proper storage of Dygase:

Store Dygase at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dygase out of the reach of children and away from pets.


General information:


  • If you have any questions about Dygase, please talk with your doctor, pharmacist, or other health care provider.

  • Dygase is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dygase. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dygase resources


  • Dygase Side Effects (in more detail)
  • Dygase Use in Pregnancy & Breastfeeding
  • Dygase Drug Interactions
  • Dygase Support Group
  • 0 Reviews for Dygase - Add your own review/rating


  • Pancrelipase Prescribing Information (FDA)

  • Pancrelipase Professional Patient Advice (Wolters Kluwer)

  • Pancrelipase Monograph (AHFS DI)

  • Creon Advanced Consumer (Micromedex) - Includes Dosage Information

  • Creon Prescribing Information (FDA)

  • Creon Consumer Overview

  • Pancreaze Consumer Overview

  • Pancreaze Prescribing Information (FDA)

  • Zenpep Prescribing Information (FDA)

  • Zenpep Consumer Overview



Compare Dygase with other medications


  • Chronic Pancreatitis
  • Cystic Fibrosis
  • Pancreatic Exocrine Dysfunction

Tuesday 9 November 2010

Etretinate




In the US, Etretinate is a member of the drug class antipsoriatics.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D05BB01

CAS registry number (Chemical Abstracts Service)

0054350-48-0

Chemical Formula

C23-H30-O3

Molecular Weight

354

Therapeutic Category

Dermatological agent: Antipsoriatic

Chemical Name

2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, ethyl ester, (all-E)-

Foreign Names

  • Etretinatum (Latin)
  • Etretinat (German)
  • Etrétinate (French)
  • Etretinato (Spanish)

Generic Names

  • Etretinate (OS: USAN, JAN, BAN)
  • Étrétinate (OS: DCF)
  • Etretinato (OS: DCIT)
  • Ro 10-9359 (IS)
  • Ro 10-9359-9 (IS)

Brand Name

  • Tigason
    Chugai, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 5 November 2010

Sulamid




Sulamid may be available in the countries listed below.


Ingredient matches for Sulamid



Amisulpride

Amisulpride is reported as an ingredient of Sulamid in the following countries:


  • Italy

International Drug Name Search

Wednesday 3 November 2010

bacitracin, neomycin, and polymyxin B ophthalmic


Generic Name: bacitracin, neomycin, and polymyxin B ophthalmic (BAS i TRAY sin, NEE oh MYE sin, POL ee MIX in off THAL mik)

Brand names: Ocu-Spore-B, Ocutricin, AK-Spore Ointment, Neocin, Neosporin ophthalmic ointment, Neo-Polycin


What is bacitracin, neomycin, and polymyxin B ophthalmic?

Bacitracin, neomycin, and polymyxin B are antibiotics that kill bacteria.


Bacitracin, neomycin, and polymyxin B ophthalmic (for the eyes) is used to treat eye infections caused by bacteria.

Bacitracin, neomycin, and polymyxin B ophthalmic may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about bacitracin, neomycin, and polymyxin B ophthalmic?


You should not use this medication if you are allergic to bacitracin, neomycin, or polymyxin B. Do not allow the tip of the ointment tube to touch any surface, including the eyes or hands. If the tip becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye. Do not share the ointment with another person.

Use this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Bacitracin, neomycin, and polymyxin B ophthalmic will not treat a viral or fungal infection of the eye.


Call your doctor if your symptoms do not improve, or if your infection gets worse while using this medication.


If you use this medication long-term, you may need frequent eye exams to make sure this medication is not causing harmful effects. Do not miss any follow-up visits to your doctor.


Bacitracin, neomycin, and polymyxin B should not be used on a child.

What should I discuss with my healthcare provider before using bacitracin, neomycin, and polymyxin B ophthalmic?


You should not use this medication if you are allergic to bacitracin, neomycin, or polymyxin B. FDA pregnancy category C. It is not known whether bacitracin, neomycin, and polymyxin B ophthalmic is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether bacitracin, neomycin, and polymyxin B ophthalmic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Bacitracin, neomycin, and polymyxin B should not be used on a child.

How should I use bacitracin, neomycin, and polymyxin B ophthalmic?


Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


Wash your hands before using bacitracin, neomycin, and polymyxin B ophthalmic ointment.


To use the ointment:



  • You may warm the ointment by holding the medicine tube in your hand for a few minutes before use. Do not remove the cap from the tube until you are ready to apply the ointment.




  • Tilt your head back slightly, and pull down gently on your lower eyelid. Apply a thin film of the ointment into your lower eyelid.




  • Close your eye and roll your eyeball around for 1 to 2 minutes.




Do not allow the tip of the ointment tube to touch any surface, including the eyes or hands. If the tip becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye. Do not share the ointment with another person.

Use this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Bacitracin, neomycin, and polymyxin B ophthalmic will not treat a viral or fungal infection of the eye.


Call your doctor if your symptoms do not improve, or if your infection gets worse while using this medication.


If you use this medication long-term, you may need frequent eye exams to make sure this medication is not causing harmful effects. Do not miss any follow-up visits to your doctor.


Store bacitracin, neomycin, and polymyxin B ophthalmic at room temperature away from moisture and heat. Keep the tube tightly capped when not in use.

What happens if I miss a dose?


Use the medication as soon as you remember the missed dose. If it is almost time for your next dose, skip the missed dose and use the medicine at your next regularly scheduled time. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


An overdose of bacitracin, neomycin, and polymyxin B ophthalmic is not likely to occur.


What should I avoid while using bacitracin, neomycin, and polymyxin B ophthalmic?


Do not use any other eye medications unless your doctor has prescribed them.


Bacitracin, neomycin, and polymyxin B ophthalmic can cause temporary blurred vision. Be careful if you drive or do anything that requires you to be able to see clearly.


Bacitracin, neomycin, and polymyxin B ophthalmic side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have a serious side effect such as:

  • severe itching, watering, redness, or swelling of your eyes;




  • eye pain;




  • crusting or drainage from your eyes; or




  • any new signs of infection.



Less serious side effects may include temporary blurred vision and mild eye irritation after using the ointment.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Bacitracin, neomycin, and polymyxin B ophthalmic Dosing Information


Usual Adult Dose for Bacterial Conjunctivitis:

Apply to the affected eye(s) every 3 to 4 hours for 7 to 10 days

Usual Adult Dose for Keratitis:

Apply to the affected eye(s) every 3 to 4 hours for 7 to 10 days

Usual Adult Dose for Keratoconjunctivitis:

Apply to the affected eye(s) every 3 to 4 hours for 7 to 10 days

Usual Adult Dose for Blepharitis:

Apply to the affected eye(s) every 3 to 4 hours for 7 to 10 days

Usual Adult Dose for Blepharoconjunctivitis:

Apply to the affected eye(s) every 3 to 4 hours for 7 to 10 days


What other drugs will affect bacitracin, neomycin, and polymyxin B ophthalmic?


It is not likely that other drugs you take orally or inject will have an effect on bacitracin, neomycin, and polymyxin B ophthalmic used in the eyes. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More bacitracin, neomycin, and polymyxin B ophthalmic resources


  • Bacitracin, neomycin, and polymyxin B ophthalmic Dosage
  • Bacitracin, neomycin, and polymyxin B ophthalmic Use in Pregnancy & Breastfeeding
  • Bacitracin, neomycin, and polymyxin B ophthalmic Support Group
  • 1 Review for Bacitracin, neomycin, and polymyxin B - Add your own review/rating


Compare bacitracin, neomycin, and polymyxin B ophthalmic with other medications


  • Blepharitis
  • Blepharoconjunctivitis
  • Conjunctivitis, Bacterial
  • Keratitis
  • Keratoconjunctivitis


Where can I get more information?


  • Your pharmacist can provide more information about bacitracin, neomycin, and polymyxin B ophthalmic.